A carregar...
The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis
The introduction of interferon beta therapies more than 20 years ago marked a milestone in the treatment of relapsing‐remitting multiple sclerosis (RRMS) with a significant impact on the approach to modern multiple sclerosis (MS) care. Key learnings and perspectives from the early days of disease mo...
Na minha lista:
| Publicado no: | Brain Behav |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5474703/ https://ncbi.nlm.nih.gov/pubmed/28638705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.696 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|